Clinical Trials Directory

Trials / Unknown

UnknownNCT05738460

Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.

The Effects of Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Early-onset Disease on Intestinal Microbiome and Immunity of Offspring

Status
Unknown
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
All
Age
37 Weeks – 41 Weeks
Healthy volunteers

Summary

This study is planned to be recruited in two hospitals in South China, Zhujiang Hospital of Southern Medical University and Zhongshan Boai Hospital Recruit participants, plan to recruit obstetrics and child health departments in study hospitals, meet inclusion and discharge criteria 1\~3 infants, a total of 360, recruited by Pearl River Hospital of Southern Medical University and Zhongshan Boai Hospital 180 people each.

Detailed description

This is a case-control study. By collecting fecal samples of infants and young children in the observation group and control group at different time points (0\~1 years old, 1\~2 years old, 2\~3 years old), the intestinal flora of infants and young children was detected by 16S rDNA sequencing, and fecal calprotectin (CP) and secretory IgA (SIgA) were detected by ELISA. To study the effects of exposure factors on intestinal flora and immunity in offspring.

Conditions

Interventions

TypeNameDescription
DRUGantibioticsReproductive tract GBS colonization group of mothers during pregnancy,Use of antibiotics

Timeline

Start date
2022-02-23
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2023-02-22
Last updated
2023-02-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05738460. Inclusion in this directory is not an endorsement.

Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity. (NCT05738460) · Clinical Trials Directory